Skip to main content
. 2022 Apr 25;17(4):e0266701. doi: 10.1371/journal.pone.0266701

Table 1. SARS-CoV2 spike protein-derived epitope peptide pools.

Peptide Mix Protein origin T cell specificity Sequence Solvent Stock conc. Final Conc. Company Purity
PepTivator SARS-CoV-2 Prot_S1 S-Protein CD4 overlapping 15-mers (aa 1–692) H2O 100 μg/mL 5 μg/mL Miltenyi >70%
PepTivator SARS-CoV-2 Prot_S S-Protein CD4 overlapping 15-mers (sequence domains aa 304–338, 421–475, 492–519, 683–707, 741–770, 785–802, and 885–1273) H2O Miltenyi >70%
PepMix™ SARS-CoV-2 (Spike Glycoprotein) S-Protein CD4 15mers with 11 aa overlap 1% DMSO JPT >70%
PepMix™ SARS-CoV-2 (Spike B.1.1.7/Alpha) S-Protein CD4 15mers with 11 aa overlap 1% DMSO JPT Crude
PepMix™ SARS-CoV-2 (Spike B.1.351/Beta) S-Protein CD4 15mers with 11 aa overlap 1% DMSO JPT Crude
PepMix™ SARS-CoV-2 (Spike P.1/Gamma) S-Protein CD4 15mers with 11 aa overlap 1% DMSO JPT Crude
PepMix™ SARS-CoV-2 (Spike B.1.617.2/Delta) S-Protein CD4 15mers with 11 aa overlap 1% DMSO JPT Crude